Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Shares Sold by Gladius Capital Management LP

Gladius Capital Management LP lowered its stake in Nature’s Sunshine Products, Inc. (NASDAQ:NATR) by 39.4% during the third quarter, HoldingsChannel reports. The institutional investor owned 4,158 shares of the company’s stock after selling 2,704 shares during the quarter. Gladius Capital Management LP’s holdings in Nature’s Sunshine Products were worth $57,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. Paradigm Capital Management Inc. NY lifted its holdings in shares of Nature’s Sunshine Products by 26.8% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 695,079 shares of the company’s stock worth $10,475,000 after acquiring an additional 146,879 shares during the last quarter. Panagora Asset Management Inc. lifted its stake in Nature’s Sunshine Products by 8.3% during the second quarter. Panagora Asset Management Inc. now owns 70,338 shares of the company’s stock worth $1,060,000 after purchasing an additional 5,392 shares in the last quarter. Janney Montgomery Scott LLC boosted its position in shares of Nature’s Sunshine Products by 8.9% during the first quarter. Janney Montgomery Scott LLC now owns 25,200 shares of the company’s stock worth $523,000 after buying an additional 2,054 shares during the period. Lazard Asset Management LLC grew its stake in shares of Nature’s Sunshine Products by 16.5% in the first quarter. Lazard Asset Management LLC now owns 7,040 shares of the company’s stock valued at $146,000 after buying an additional 998 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of Nature’s Sunshine Products by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 659,686 shares of the company’s stock valued at $13,702,000 after buying an additional 3,792 shares during the period. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a report on Friday, September 13th. They set a “buy” rating and a $18.00 target price for the company. StockNews.com raised shares of Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 10th. DA Davidson cut their target price on shares of Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, August 12th. Finally, Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a research report on Friday, September 13th. They issued a “buy” rating and a $18.00 price target for the company.

Insider Activity at Nature’s Sunshine Products

In other Nature’s Sunshine Products news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of Nature’s Sunshine Products stock in a transaction dated Thursday, October 10th. The stock was sold at an average price of $13.39, for a total transaction of $40,170.00. Following the completion of the sale, the insider now directly owns 69,347 shares of the company’s stock, valued at $928,556.33. The trade was a 4.15 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders have sold a total of 7,499 shares of company stock valued at $99,802 over the last 90 days. 4.70% of the stock is owned by corporate insiders.

Nature’s Sunshine Products Stock Performance

Shares of NATR opened at $16.00 on Friday. Nature’s Sunshine Products, Inc. has a 1 year low of $10.81 and a 1 year high of $21.72. The stock has a market capitalization of $295.68 million, a PE ratio of 18.18 and a beta of 0.87. The stock has a 50-day simple moving average of $13.64 and a 200-day simple moving average of $14.61.

Nature’s Sunshine Products Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.